Histone Deacetylase Inhibitors in Cancer

Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 70, Issue 11

Abstract

The epigenetic modifications can change the state of a part of the DNA by different enzymes such as the histone deacetylases. Dysregulation of the epigenetic mechanisms is associated with the initiation and progression of cancer. The reversibility of this dysregulation in epigenetic modifications makes it an attractive target for cancer therapy and drug discovery scientists. We conducted a computerized Literature search involving human subjects, published in English until December 2017, and indexed through Medical Databases; MEDLINE/PubMed, EMBASE, and Web of Science. We reviewed articles performed for prospective and other types of studies related to histone deacetylases inhibitors which can help cancer patient’s status during the therapy. Several investigational drugs for cancer therapy are in clinical trials. Interestingly, US Food and Drug Administration has already approved four histone deacetylases inhibitors drugs for hematological malignancies but not for solid tumors. Currently, different histone deacetylases inhibitors are under study for both hematological and solid tumors as single agents or in combinations. In this review, we will discuss some the approved histone deacetylases inhibitors, and the one in clinical trials.

Authors and Affiliations

Eman Helal

Keywords

Related Articles

Comparative Randomized Controlled Blind Study of the Anti-Shivering Effect of Hydrocortisone, Granisetron and Meperidine in Post-Spinal Anesthesia in Patients Undergoing Cesarean Section

<span>Background: </span><span>it was observed that a considerable proportion of patients undergoing surgery experience intraoperative and postoperative hypothermia and it was found that misregulation of body temperature...

Prevalence of Right Ventricular Dysfunction in relation to Type of Vascular Access in Chronic Hemodialysis Patients: Monocentric Study

<strong>Background:</strong> chronic renal failure (CRF) is associated with significantly increased morbidity and mortality. Chronic renal failure affects almost every system of the body and results in various functional...

Correlation between Axial Length and Macular Thickness in Myopia

<strong>Background: </strong>Myopia is the most common error of refraction and, in many countries; complications related to high myopia are a major cause of blindness.   The prevalence of myopia has been reported as high...

Study of Behavioral Deficits Elicited by Exposure to Lipopolysacaride /Chronic Mild Stress in Male Wistar Rats

<strong>Background: </strong>depression may be considered "the disease of the modern era". With a high prevalence worldwide causing significant morbidity and mortality and constituting a heavy burden on social and econom...

Prevalence of Factors That Can Increase the Risk of Hip Fracture and Its Complications after Surgery

Background: hip fractures are defined as any fracture of the femur between the articular cartilage of the hip joint to 5 cm below the distal point of the lesser trochanter; they can occur at any age, they but are most co...

Download PDF file
  • EP ID EP583754
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

Eman Helal (2018). Histone Deacetylase Inhibitors in Cancer. The Egyptian Journal of Hospital Medicine, 70(11), 1929-1935. https://europub.co.uk/articles/-A-583754